tert-Butyl 3-[(3-bromophenyl)methyl]azetidine-1-carboxylate

Catalog No. :
ACAGDE596
CAS No. :
2044713-99-5
Molecular Formula :
C15H20BrNO2
Molecular Weight :
326.23

IUPAC Name:tert-butyl 3-(3-bromobenzyl)azetidine-1-carboxylate

tert-Butyl 3-[(3-bromophenyl)methyl]azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$333.00Login to see priceInquiryInquiry
100mg95%$489.00Login to see priceInquiryInquiry
250mg95%$694.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-[(3-bromophenyl)methyl]azetidine-1-carboxylate
IUPAC Nametert-butyl 3-(3-bromobenzyl)azetidine-1-carboxylate
MDL No.MFCD30476155
Molecular FormulaC15H20BrNO2
Molecular Weight326.23
SMILESO=C(N1CC(CC2=CC=CC(Br)=C2)C1)OC(C)(C)C
InChI KeyJHGYSADJWWUTJH-UHFFFAOYSA-N
Synonymtert-butyl 3-[(3-bromophenyl)methyl]azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-[(3-bromophenyl)methyl]-, 1,1-dimethylethyl ester
CAS No.2044713-99-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAGDE596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTKWO406 route compound structure diagram
    ACTKWO406253176-94-2 In Stock
  4. Then
  5. ACAGDE596 route product structure diagram
    ACAGDE5962044713-99-5
Inquiry

2. ACAGDE596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAGDE596 route product structure diagram
    ACAGDE5962044713-99-5
Inquiry

Comments (0)